LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-2.06%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.18B
AUM Growth
+$1.18B
(-0.2%)
Cap. Flow
+$15.5M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
24.05%
Holding
357
New
34
Increased
31
Reduced
193
Closed
83
Top Buys
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$35.8M |
| 2 |
iShares Russell 2000 Growth ETF
IWO
|
$33.7M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
$29.3M |
| 4 |
Pfizer
PFE
|
$17.4M |
| 5 |
Globe Life
GL
|
$9.97M |
Top Sells
| 1 |
Visa
V
|
$14.5M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$12M |
| 3 |
LHCG
LHC Group LLC
LHCG
|
$10.6M |
| 4 |
BioNTech
BNTX
|
$10.1M |
| 5 |
Republic Services
RSG
|
$5.59M |
Sector Composition
| 1 | Healthcare | 41.98% |
| 2 | Financials | 15.26% |
| 3 | Consumer Discretionary | 12.3% |
| 4 | Technology | 7.74% |
| 5 | Industrials | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIXX
1
DELISTED
CI Financial Corp.
CIXX
| $36.3M | 3.08% |
2,000,000
| – | – |
|
|
2
iShares Russell 1000 Value ETF
IWD
$63.5B
| $35.8M | 3.03% |
+263,100
| New | +$35.8M |
|
3
Manulife Financial
MFC
$52.2B
| $35.7M | 3.03% |
1,200,000
+195,730
| +19% | +$5.82M |
|
|
4
iShares Russell 2000 Growth ETF
IWO
$12.4B
| $33.7M | 2.86% |
+163,200
| New | +$33.7M |
|
|
5
iShares MSCI EAFE Value ETF
EFV
$27.8B
| $29.3M | 2.48% |
+759,800
| New | +$29.3M |
|
6
Thermo Fisher Scientific
TMO
$186B
| $23.9M | 2.03% |
47,091
-5,904
| -11% | -$2.99M |
|
7
CVS Health
CVS
$92.8B
| $23.2M | 1.97% |
243,288
-51,881
| -18% | -$4.95M |
|
8
Service Corp International
SCI
$11.1B
| $23.1M | 1.96% |
400,000
| – | – |
|
9
Ameriprise Financial
AMP
$48.5B
| $21.4M | 1.82% |
85,000
-5,448
| -6% | -$1.37M |
|
10
Neurocrine Biosciences
NBIX
$13.8B
| $21.1M | 1.79% |
199,092
-15,838
| -7% | -$1.68M |
|
11
IQVIA
IQV
$32.4B
| $20.8M | 1.77% |
115,000
-7,124
| -6% | -$1.29M |
|
12
Bristol-Myers Squibb
BMY
$96B
| $20.5M | 1.74% |
288,394
-5,237
| -2% | -$372K |
|
13
DexCom
DXCM
$29.5B
| $20.1M | 1.71% |
249,848
-13,016
| -5% | -$1.05M |
|
14
Brunswick
BC
$4.15B
| $19.6M | 1.67% |
300,000
+25,000
| +9% | +$1.64M |
|
15
Thor Industries
THO
$5.79B
| $19.2M | 1.63% |
275,000
| – | – |
|
16
BioMarin Pharmaceuticals
BMRN
$11.2B
| $18.9M | 1.6% |
222,938
-27,579
| -11% | -$2.34M |
|
|
17
Pfizer
PFE
$141B
| $18.9M | 1.6% |
430,898
+396,891
| +1,167% | +$17.4M |
|
18
Charles Schwab
SCHW
$174B
| $18.3M | 1.55% |
254,021
-4,317
| -2% | -$310K |
|
19
UnitedHealth
UNH
$281B
| $18M | 1.53% |
35,683
-7,748
| -18% | -$3.91M |
|
20
Hologic
HOLX
$14.9B
| $17.7M | 1.5% |
275,000
-27,309
| -9% | -$1.76M |
|
21
Incyte
INCY
$16.5B
| $17.7M | 1.5% |
266,073
-7,748
| -3% | -$516K |
|
22
AbbVie
ABBV
$372B
| $17.4M | 1.48% |
129,728
-5,758
| -4% | -$773K |
|
23
Lowe's Companies
LOW
$145B
| $17.3M | 1.47% |
92,254
-13,226
| -13% | -$2.48M |
|
24
Apple
AAPL
$3.45T
| $17.3M | 1.47% |
125,234
+2,200
| +2% | +$304K |
|
25
American Express
AXP
$231B
| $16.5M | 1.4% |
122,175
+9,003
| +8% | +$1.21M |
|